Toronto Joint Department of Medical Imaging, University Health Network - Mt Sinai Hospital - Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
Urology. 2022 Nov;169:150-155. doi: 10.1016/j.urology.2022.07.002. Epub 2022 Jul 16.
To determine the detection of clinically significant prostate cancer (csPCa) index lesion using high resolution transrectal micro-ultrasound (MicroUS) applying PRI-MUS (Prostate Risk Identification using Micro Ultrasound) score v1.0.
Men who underwent radical prostatectomy following biopsy and MicroUS assessment were included. MicroUS dynamic cine loops of these patients were retrospectively reviewed by an experienced radiologist. The radiologist was aware that patients had undergone radical prostatectomy but was blinded to pathological data. Suspicious sites were assigned a PRI-MUS score. Radical prostatectomy specimens were examined with the quarter mount technique. Detection rate of csPCa index lesion [Grade Group (GG) ≥2] by MicroUS was assessed at a patient level.
Twenty-five participants were included in the analysis. The median age was 65.5 years (range 56-74). Median PSA was 6.45 ng/dL (range 2-31.72). Two of 25 patients did not have csPCa (GG1 disease) on radical prostatectomy. MicroUS visualized 20/23 (87%) of the csPCa index lesions [median length 9 mm (range 1.5- 28.5)]. All identified lesions were categorized PRIMUS score 4 or 5. The 3 missed index lesions were in the transition zone [median length 10.5 mm (range 4.5-22.5)]. MicroUS missed 11 non index csPCa in 9 participants [median length 1.5 mm (range 1.5-10.5)]. Of these, 8 were GG2, 2 GG3 and 1 GG5. MicroUS identified the csPCa index lesion in all 9 of these men.
MicroUS showed the high sensitivity (87%) in detecting index lesions in the prostate gland and identified 100% of index lesions in the peripheral zone.
应用 PRI-MUS(基于微超声的前列腺风险识别)评分 v1.0 确定高分辨率经直肠微超声(MicroUS)检测临床上显著前列腺癌(csPCa)的指数病变。
纳入接受根治性前列腺切除术且接受 MicroUS 评估的患者。由一位经验丰富的放射科医生对这些患者的 MicroUS 动态电影循环进行回顾性分析。放射科医生知道患者接受了根治性前列腺切除术,但对病理数据不知情。可疑部位被分配了 PRI-MUS 评分。使用四分位挂载技术检查根治性前列腺切除标本。在患者水平评估 MicroUS 检测 csPCa 指数病变(分级组 [GG]≥2)的检出率。
共纳入 25 名参与者进行分析。中位年龄为 65.5 岁(范围 56-74)。中位 PSA 为 6.45ng/dL(范围 2-31.72)。25 名患者中有 2 名(GG1 疾病)在根治性前列腺切除术后未患有 csPCa。MicroUS 可视化了 20/23(87%)个 csPCa 指数病变[中位数长度 9mm(范围 1.5-28.5)]。所有确定的病变均被归类为 PRIMUS 评分 4 或 5。3 个漏诊的指数病变位于移行区[中位数长度 10.5mm(范围 4.5-22.5)]。MicroUS 在 9 名患者中漏诊了 11 个非指数 csPCa[中位数长度 1.5mm(范围 1.5-10.5)]。其中 8 个为 GG2,2 个为 GG3,1 个为 GG5。MicroUS 在这 9 名男性中均识别出了 csPCa 指数病变。
MicroUS 在检测前列腺内的指数病变时显示出较高的敏感性(87%),并在周边区识别出了 100%的指数病变。